Federated Hermes’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $866M | Buy |
3,980,171
+181,959
| +5% | +$40.4M | 1.41% | 5 |
|
|
2025
Q4 | $868M | Sell |
3,798,212
-227,773
| -6% | -$51.9M | 1.45% | 6 |
|
|
2025
Q3 | $932M | Buy |
4,025,985
+607,653
| +18% | +$124M | 1.65% | 4 |
|
|
2025
Q2 | $635M | Buy |
3,418,332
+134,942
| +4% | +$25.1M | 1.19% | 6 |
|
|
2025
Q1 | $688M | Buy |
3,283,390
+716,468
| +28% | +$139M | 1.48% | 4 |
|
|
2024
Q4 | $456M | Buy |
2,566,922
+697,643
| +37% | +$128M | 1% | 9 |
|
|
2024
Q3 | $369M | Buy |
1,869,279
+48,758
| +3% | +$9.1M | 0.81% | 18 |
|
|
2024
Q2 | $312M | Buy |
1,820,521
+32,708
| +2% | +$5.42M | 0.74% | 26 |
|
|
2024
Q1 | $326M | Sell |
1,787,813
-504,840
| -22% | -$87M | 0.75% | 25 |
|
|
2023
Q4 | $355M | Buy |
2,292,653
+437,672
| +24% | +$63.8M | 0.88% | 18 |
|
|
2023
Q3 | $277M | Buy |
1,854,981
+12,663
| +0.7% | +$1.86M | 0.74% | 24 |
|
|
2023
Q2 | $248M | Sell |
1,842,318
-784,659
| -30% | -$115M | 0.62% | 31 |
|
|
2023
Q1 | $419M | Sell |
2,626,977
-29,143
| -1% | -$4.46M | 1.05% | 13 |
|
|
2022
Q4 | $429M | Buy |
2,656,120
+228,140
| +9% | +$35M | 1.19% | 10 |
|
|
2022
Q3 | $326M | Sell |
2,427,980
-183,878
| -7% | -$26.4M | 0.95% | 14 |
|
|
2022
Q2 | $400M | Sell |
2,611,858
-1,289,081
| -33% | -$197M | 1.09% | 8 |
|
|
2022
Q1 | $632M | Sell |
3,900,939
-1,264,452
| -24% | -$184M | 1.43% | 3 |
|
|
2021
Q4 | $699M | Buy |
5,165,391
+117,783
| +2% | +$13.9M | 1.3% | 4 |
|
|
2021
Q3 | $544M | Sell |
5,047,608
-3,309
| -0.1% | -$378K | 1.04% | 9 |
|
|
2021
Q2 | $569M | Sell |
5,050,917
-81,755
| -2% | -$9.21M | 1.06% | 7 |
|
|
2021
Q1 | $555M | Sell |
5,132,672
-54,512
| -1% | -$5.83M | 1.08% | 6 |
|
|
2020
Q4 | $556M | Sell |
5,187,184
-405,822
| -7% | -$39M | 1.14% | 7 |
|
|
2020
Q3 | $490M | Sell |
5,593,006
-973,543
| -15% | -$91.7M | 1.15% | 8 |
|
|
2020
Q2 | $645M | Sell |
6,566,549
-1,596,712
| -20% | -$141M | 1.6% | 2 |
|
|
2020
Q1 | $622M | Sell |
8,163,261
-293,090
| -3% | -$25M | 1.83% | 3 |
|
|
2019
Q4 | $749M | Sell |
8,456,351
-154,167
| -2% | -$12.8M | 1.67% | 4 |
|
|
2019
Q3 | $652M | Buy |
8,610,518
+631,857
| +8% | +$43.3M | 1.6% | 4 |
|
|
2019
Q2 | $580M | Sell |
7,978,661
-17,629
| -0.2% | -$1.39M | 1.41% | 8 |
|
|
2019
Q1 | $644M | Buy |
7,996,290
+1,623,690
| +25% | +$133M | 1.59% | 8 |
|
|
2018
Q4 | $587M | Buy |
6,372,600
+2,702,968
| +74% | +$238M | 1.6% | 9 |
|
|
2018
Q3 | $347M | Buy |
3,669,632
+1,469,718
| +67% | +$139M | 0.81% | 21 |
|
|
2018
Q2 | $204M | Sell |
2,199,914
-620,922
| -22% | -$60.6M | 0.6% | 28 |
|
|
2018
Q1 | $267M | Sell |
2,820,836
-3,377,602
| -54% | -$371M | 0.78% | 24 |
|
|
2017
Q4 | $599M | Sell |
6,198,438
-4,437,598
| -42% | -$418M | 1.69% | 12 |
|
|
2017
Q3 | $945M | Sell |
10,636,036
-4,493,187
| -30% | -$342M | 2.71% | 4 |
|
|
2017
Q2 | $1.1B | Sell |
15,129,223
-326,904
| -2% | -$22M | 3.16% | 1 |
|
|
2017
Q1 | $1.01B | Buy |
15,456,127
+398,077
| +3% | +$25M | 2.87% | 3 |
|
|
2016
Q4 | $943M | Buy |
15,058,050
+94,872
| +0.6% | +$5.79M | 2.83% | 3 |
|
|
2016
Q3 | $944M | Buy |
14,963,178
+1,647,581
| +12% | +$107M | 2.72% | 5 |
|
|
2016
Q2 | $824M | Buy |
13,315,597
+1,911,448
| +17% | +$116M | 2.41% | 7 |
|
|
2016
Q1 | $651M | Buy |
11,404,149
+11,116,084
| +3,859% | +$620M | 2.02% | 9 |
|
|
2015
Q4 | $17.1M | Sell |
288,065
-364,082
| -56% | -$21M | 0.05% | 305 |
|
|
2015
Q3 | $35.5M | Sell |
652,147
-493,241
| -43% | -$32.1M | 0.11% | 179 |
|
|
2015
Q2 | $77M | Buy |
1,145,388
+1,926
| +0.2% | +$126K | 0.23% | 85 |
|
|
2015
Q1 | $66.9M | Buy |
1,143,462
+565,894
| +98% | +$34.2M | 0.2% | 100 |
|
|
2014
Q4 | $37.8M | Sell |
577,568
-87,997
| -13% | -$5.55M | 0.12% | 166 |
|
|
2014
Q3 | $38.4M | Sell |
665,565
-3,652,275
| -85% | -$203M | 0.12% | 163 |
|
|
2014
Q2 | $244M | Buy |
4,317,840
+268,769
| +7% | +$14.1M | 0.76% | 26 |
|
|
2014
Q1 | $208M | Sell |
4,049,071
-4,148,900
| -51% | -$210M | 0.7% | 27 |
|
|
2013
Q4 | $433M | Sell |
8,197,971
-457,695
| -5% | -$22.5M | 1.5% | 10 |
|
|
2013
Q3 | $387M | Sell |
8,655,666
-186,676
| -2% | -$8.27M | 1.49% | 11 |
|
|
2013
Q2 | $366M | Buy |
+8,842,342
| New | +$387M | 1.45% | 12 |
|
Other funds holding ABBV
VCM
VPM
Federated Hermes's ABBV Position: Q1 2026 in Review
Federated Hermes increased its AbbVie (ABBV) stake by 4.8% in Q1 2026, buying an estimated $40.4M and bringing the position to 3,980,171 shares worth $866M. The position accounts for 1.41% of the portfolio, ranked #5.
Federated Hermes first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.1B in Q2 2017. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Federated Hermes held 3,980,171 shares of AbbVie worth $866M as of Q1 2026.
- Federated Hermes bought 181,959 AbbVie shares in Q1 2026, an estimated $40.4M.
- AbbVie made up 1.41% of Federated Hermes's portfolio in Q1 2026, its #5 holding.
- Federated Hermes first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Federated Hermes's AbbVie position peaked at $1.1B in Q2 2017.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.